Education
About Us
Working with TipRanks
Follow Us
Stephen Rusckowski Insider Profile
4 Followers
Stephen Rusckowski, Director at Quest Diagnostics, holds 9.07K shares in Baxter International (Ticker: BAX), holds 2.85K shares in Tenet Healthcare (Ticker: THC), holds 389.60K shares in Quest Diagnostics (Ticker: DGX).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-5.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen Rusckowski holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stephen Rusckowski
Stephen Rusckowski's Trading History
Quest Diagnostics
Mar 08, 2023
Director
Uninformative Buy
12.22M
$68.40M
Tenet Healthcare
May 30, 2023
Director
Uninformative Buy
―
$362.84K
Baxter International
May 09, 2024
Director
Uninformative Buy
―
$331.62K
Xerox
Jan 16, 2018
Director
Uninformative Buy
89.99K
$114.17K
Covidien
Jan 28, 2015
―
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see Stephen Rusckowski's performance on stock
You May Also Like
Stephen Rusckowski insider profile FAQ
What is the percentage of profitable transactions made by Stephen Rusckowski?
The percentage of profitable transactions made by Stephen Rusckowski is 50%.
What is the average return per transaction made by Stephen Rusckowski?
The average return per transaction made by Stephen Rusckowski is -5.00%.
What stocks does Stephen Rusckowski hold?
Stephen Rusckowski holds: DGX, THC, BAX, XRX, COV stocks.
What was Stephen Rusckowski’s latest transaction?
Stephen Rusckowski latest transaction was an Uninformative Buy of ―.
What was Stephen Rusckowski's most profitable transaction?
Stephen Rusckowski’s most profitable transaction was an Informative Sell of DGX stock on May 25, 2022. The return on the trade was 4.00%.
What is Stephen Rusckowski's role in Quest Diagnostics?
Stephen Rusckowski's role in Quest Diagnostics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.